The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
Costly Drugs Beyond Reach of Middle-Class Patients
Posted
December 31, 2015
Views
2,165
Likes
27
Comments
3
Engagement
December 31, 2015
2,165
27
3
1.39%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
3:09Now PlayingJacqueline Racener's doctor recommended a drug called Imbruvica to treat her leukemia. The catch: Her annual income at the time disqualified her for copay-assistance programs for the costly treatment. Photo: Whitney Curtis for The Wall Street Journal
Subscribe to the WSJ channel here:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
